Skip to main content.

Targeting pain

at the basivertebral nerve

OptaBlate®
basivertebral nerve ablation system

Introducing OptaBlate BVN. A targeted, minimally invasive procedure that provides long-lasting vertebrogenic pain relief.1*

Built on experience.

At Stryker, we have a long history in radiofrequency ablation. We’ve continued to advance the science of delivering large lesions fast.2 Our commitment to providing solutions to reduce pain now continues at the basivertebral nerve.

Designed for efficiency.

Four channels. Faster ablation2

The OptaBlate BVN system provides four channels for faster, simultaneous ablations—at least 1cm ablation in seven minutes.2

A curve you control

For easy access and improved targeting, the OptaBlate BVN system is designed to provide smooth entry down the 10-gauge cannula and a controlled curve in the vertebral body.

Established reliability

Our Microinfuser3 technology is designed to reduce impedance errors and prevent charring for quicker, more consistent ablations.2

Contact us for a product demonstration or more information

At Stryker, we are partnering with you to make healthcare better. Reach out to discover our interventional solutions that are designed to help relieve pain and improve quality of life.

There are several outstanding features of [OptaBlate BVN].

Targeting is everything—being able to target the basivertebral nerve where it resides is critical. That, coupled with a radiofrequency ablation generator, allows you to ablate multiple nerves simultaneously."

— Dr. Jad Khalil, Orthopedic Spine Surgeon

I had the opportunity to do hands-on training with the OptaBlate BVN.

The system is simple yet effective, offering reproducibility with the needle curve and access system. It performed well on both hard and soft bone, consistently reaching the target without issues. It’s reassuring to know this isn’t a Gen-1 system with a quick Gen-2 upgrade on the horizon—the system is already set up for success."

— Dr. Jack Smith, Pain Management Physician

*The evidence shows patients treated with basivertebral nerve ablation (BVNA) had sustained benefits in pain and function for up to five years.

Warning/adverse events:
As with most surgical procedures, serious adverse events can occur, including bleeding, infection, nerve damage and increased back pain. This procedure is not for everyone.

Please see Instructions for Use (IFU) for a complete listing of warnings, precautions and adverse events.

The individual(s) may have or have had a financial or advisory relationship with Stryker.